Difficulty: Medium
Average Score: 95%
Practice
Oral medications are often used as an early treatment for generalized spasticity. Which of the following works at the level of skeletal muscle to block calcium release from the sarcoplasmic reticulum?
Correct answer
A
Rationale
In the context of pediatric practice, understanding the mechanisms of action of medications used for spasticity management is crucial. The correct answer is A) dantrolene sodium. Dantrolene works at the level of skeletal muscle by directly blocking calcium release from the sarcoplasmic reticulum. This action helps to reduce muscle contraction and spasticity, making it an effective early treatment for generalized spasticity.
Now, let's discuss why the other options are incorrect:
- B) Clonidine primarily acts as a centrally acting alpha-2 adrenergic agonist, targeting the central nervous system to reduce sympathetic outflow. It is not directly involved in blocking calcium release from the sarcoplasmic reticulum in skeletal muscle.
- C) Tizanidine is another centrally acting alpha-2 adrenergic agonist that works by reducing spasticity through its effect on the central nervous system, rather than at the level of skeletal muscle.
- D) Baclofen is a GABA receptor agonist that acts at the spinal cord level to reduce muscle spasticity. It does not directly block calcium release from the sarcoplasmic reticulum in skeletal muscle.
Educationally, understanding the specific mechanisms of action of medications used in pediatric spasticity management not only helps in answering exam questions correctly but also enhances clinical decision-making skills when caring for pediatric patients with spasticity disorders. This knowledge is essential for safe and effective medication administration and optimal patient outcomes.
Now, let's discuss why the other options are incorrect:
- B) Clonidine primarily acts as a centrally acting alpha-2 adrenergic agonist, targeting the central nervous system to reduce sympathetic outflow. It is not directly involved in blocking calcium release from the sarcoplasmic reticulum in skeletal muscle.
- C) Tizanidine is another centrally acting alpha-2 adrenergic agonist that works by reducing spasticity through its effect on the central nervous system, rather than at the level of skeletal muscle.
- D) Baclofen is a GABA receptor agonist that acts at the spinal cord level to reduce muscle spasticity. It does not directly block calcium release from the sarcoplasmic reticulum in skeletal muscle.
Educationally, understanding the specific mechanisms of action of medications used in pediatric spasticity management not only helps in answering exam questions correctly but also enhances clinical decision-making skills when caring for pediatric patients with spasticity disorders. This knowledge is essential for safe and effective medication administration and optimal patient outcomes.